Fellowbook News

Vanderbilt performs world’s first heart, lung transplant of COVID-19 patient

Vanderbilt University Medical Center says it performed the world’s first dual heart-lung transplant of a COVID-19 patient in September.

Vanderbilt says the patient, described as a young man, had cardiomyopathy – a disease of the heart tissue that can lead to heart failure – before he contracted COVID-19 in June.

The procedure, which was completed on Sept. 24, was also Vanderbilt’s first heart-lung transplant since 2006. Ashish Shah, MD, professor and chair of Cardiac Surgery, performed the complex surgery, along with Matthew Bacchetta, MD, MBA, associate professor of Thoracic Surgery… Continue reading.

More News from Matthew Bacchetta, MD

New method enables recovery of hearts from deceased organ donors after circulatory death
Vanderbilt University Medical Center researchers have developed a groundbreaking new method for the recovery of hearts from deceased organ donors after circulatory death (DCD). The method (rapid recovery with extended ultra-oxygenated preservation [REUP]),...
Donation After Circulatory Death Kidney Transplant Outcomes Not Affected by Wait Time
Extending wait time criteria from 1 to 3 hours after withdrawal of life-sustaining treatment for kidney donation after circulatory death (DCD) does not compromise kidney transplant outcomes and may help ease the organ shortage, investigators report. The...
Process rehabilitates donor livers for transplantation
Not enough suitable donor livers are available, meaning that patients nationwide die every day while waiting on the transplant list. But a multidisciplinary team from Vanderbilt University Medical Center recently published research that shows promise...
Bacchetta named chair of Thoracic Surgery
Matthew Bacchetta, MD, MBA, MA, associate professor of Thoracic Surgery, has assumed his new role as chair of Vanderbilt University Medical Center’s Department of Thoracic Surgery, as of July 2021. Bacchetta, an internationally renowned National Institutes...
Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs
Medical, surgical and technological advancements in organ transplantation continue to expand life-saving treatment options for patients with end-stage lung disease, but transplantation remains limited by the low availability of donor organs. As chronic...